EVP, Head of R&D · Dianthus Therapeutics, Inc. /DE/ · Common Stock
Side
M
Value
$134K
Shares
7,500
Price
$17.88
Executed
Sep 1, 2026
Disclosed
Sep 3, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Sep 1 executedSep 3, 2026 disclosed
DNTH · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+16 / 25
$134K reported value · 187.5% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+1 / 15
Routine: 8 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Randhawa Simrat filed this Form 4 reporting a option exercise of DNTH on Sep 1, 2026. It became public on Sep 3, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
EVP, Head of R&D
Randhawa Simratcik:0001992260
Issuer
Dianthus Therapeutics, Inc. /DE/cik:0001690585
Revision history · 0
No field has changed since this record was first ingested.
